Duygen Tablet 60/2.5 mg (Pimasartan Potassium Trihydrate, Amlodipine Besilate)
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
CTC Bio, Co., Ltd.
MFDS item code 202300121 · Approved 2023.01.06 · Insurance code 669502740
This product's status changed to Approval withdrawn on 2025.08.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Pimasartan Potassium. It helps effectively manage blood pressure in cases where control is not sufficient with existing monotherapy. This contributes to reducing the risk of complications caused by hypertension and maintaining cardiovascular health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, direct switching to this medicine may be considered if blood pressure is not controlled, as follows. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required for elderly patients aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients who have allergies to this medication's active ingredients or similar substances, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with severe liver function impairment, patients with biliary obstruction, certain diabetic patients, specific renal impairment patients, genetically lactose intolerant patients, patients with severe aortic stenosis, and those in shock should not take this medication. Patients with decreased blood volume or sodium, impaired kidney function, renovascular hypertension, aortic and mitral stenosis, primary aldosteronism, severe hypotension, the elderly, and patients with hypersensitivity to certain pigments should take this medication with caution. While taking this medication, side effects such as dizziness, headache, facial or limb edema, urination disorders, insomnia, flushing, etc., may occur, and if any abnormal symptoms arise, consultation with a physician is necessary. Hypotension symptoms may arise during treatment, so especially at the beginning of treatment or when increasing the dosage, the patient's condition should be closely monitored, and if symptoms become severe, they should lie down or receive fluid treatment if necessary. This medication may elevate potassium levels in the blood, so patients with heart failure or impaired kidney function should regularly monitor their blood potassium levels. This medication may interact with other blood pressure medications, diuretics, potassium supplements, certain antibiotics, and anti-inflammatories, so if you are taking other medications, be sure to inform your doctor or pharmacist. This medication may cause drowsiness or dizziness during driving or machine operation, so caution is advised. Women who are pregnant or breastfeeding should avoid taking this medication or consult with their doctor, and safety for children and adolescents under 18 years of age has not been established. In case of overdose, severe hypotension or cardiac arrhythmias may occur, so immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a container that does not allow light to enter. Additionally, it is recommended to keep the medication at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.
Yellow, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
CTC Bio, Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.